rs150917517

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP7BS1_SupportingBS2

The NM_000061.3(BTK):​c.390C>T​(p.Asn130=) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000025 in 1,202,198 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000092 ( 0 hom., 2 hem., cov: 22)
Exomes 𝑓: 0.000018 ( 0 hom. 6 hem. )

Consequence

BTK
NM_000061.3 splice_region, synonymous

Scores

2
Splicing: ADA: 0.001158
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.984
Variant links:
Genes affected
BTK (HGNC:1133): (Bruton tyrosine kinase) The protein encoded by this gene plays a crucial role in B-cell development. Mutations in this gene cause X-linked agammaglobulinemia type 1, which is an immunodeficiency characterized by the failure to produce mature B lymphocytes, and associated with a failure of Ig heavy chain rearrangement. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP7
Synonymous conserved (PhyloP=-0.984 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0000916 (10/109143) while in subpopulation AFR AF= 0.000301 (9/29905). AF 95% confidence interval is 0.000157. There are 0 homozygotes in gnomad4. There are 2 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Hemizygotes in GnomAd4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
BTKNM_000061.3 linkuse as main transcriptc.390C>T p.Asn130= splice_region_variant, synonymous_variant 5/19 ENST00000308731.8
BTKNM_001287344.2 linkuse as main transcriptc.492C>T p.Asn164= splice_region_variant, synonymous_variant 5/19
BTKNM_001287345.2 linkuse as main transcriptc.390C>T p.Asn130= splice_region_variant, synonymous_variant 6/17

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
BTKENST00000308731.8 linkuse as main transcriptc.390C>T p.Asn130= splice_region_variant, synonymous_variant 5/191 NM_000061.3 P3Q06187-1

Frequencies

GnomAD3 genomes
AF:
0.0000916
AC:
10
AN:
109143
Hom.:
0
Cov.:
22
AF XY:
0.0000628
AC XY:
2
AN XY:
31845
show subpopulations
Gnomad AFR
AF:
0.000301
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000190
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000220
AC:
4
AN:
182216
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
67098
show subpopulations
Gnomad AFR exome
AF:
0.000307
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000183
AC:
20
AN:
1093055
Hom.:
0
Cov.:
29
AF XY:
0.0000167
AC XY:
6
AN XY:
358853
show subpopulations
Gnomad4 AFR exome
AF:
0.000114
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000248
Gnomad4 NFE exome
AF:
0.0000191
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000916
AC:
10
AN:
109143
Hom.:
0
Cov.:
22
AF XY:
0.0000628
AC XY:
2
AN XY:
31845
show subpopulations
Gnomad4 AFR
AF:
0.000301
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000190
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000624
Hom.:
2
Bravo
AF:
0.0000907

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

X-linked agammaglobulinemia with growth hormone deficiency Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeApr 01, 2022This sequence change affects codon 130 of the BTK mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the BTK protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs150917517, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with BTK-related conditions. ClinVar contains an entry for this variant (Variation ID: 573075). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
4.7
DANN
Benign
0.76
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0012
dbscSNV1_RF
Benign
0.044
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs150917517; hg19: chrX-100624987; API